Evidence map›Paper›PMID 31452934›Full record

ArticleResearch involvement and engagement2019

Adapting the James Lind Alliance priority setting process to better support patient participation: an example from cystic fibrosis.

N J Rowbotham, S J Smith, Z C Elliott, P A Leighton, O C Rayner, R Morley, A R Smyth

Abstract read
In one paragraph

Article in Research involvement and engagement, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Opportunities and pitfalls of social media research in rare genetic diseases: a systematic review.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Pooled it
  4. Trial
  5. Research priorities for intensive care: A stakeholder-informed priority-setting partnership.Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine · 2026
    Article
  6. Article
  7. Article
  8. Overarching Priorities for Health and Care Research in the United Kingdom: A Coproduced Synthesis of James Lind Alliance 'Top 10s'.Health expectations : an international journal of public participation in health care and health policy · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Is Post-Burn Scarring a Research Priority?European burn journal · 2022
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Coming Full Circle: Reflections and Inspirations from a Cystic Fibrosis Patient Scientist Panel.Inquiry : a journal of medical care organization, provision and financing
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

N J Rowbotham1Division of Child Health, Obstetrics & Gynaecology, Evidence Based Child Health Group, Obstetrics & Gynaecology, Queens Medical Centre, University of Nottingham, E Floor East Block, Nottingham, NG7 2UH UK.
S J Smith1Division of Child Health, Obstetrics & Gynaecology, Evidence Based Child Health Group, Obstetrics & Gynaecology, Queens Medical Centre, University of Nottingham, E Floor East Block, Nottingham, NG7 2UH UK.
Z C ElliottParent of children with CF, Nottingham, UK.
P A Leighton3Faculty of Medicine & Health Sciences, University of Nottingham, Nottingham, UK.
O C RaynerPerson with CF, Plymouth, UK.
R Morley5James Lind Alliance, York, UK.
A R Smyth1Division of Child Health, Obstetrics & Gynaecology, Evidence Based Child Health Group, Obstetrics & Gynaecology, Queens Medical Centre, University of Nottingham, E Floor East Block, Nottingham, NG7 2UH UK.ORCID 0000-0001-5494-5438

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

plain english summaryCystic fibrosis (CF) is the commonest life-limiting inherited disorder in the UK. It affects many parts of the body including the lungs and gut leading to increased infection and problems digesting food. People with CF need to undergo many treatments each day throughout their whole lives. These include tablets, inhalers and breathing exercises, which are a huge burden, taking up several hours every dayIt is therefore, really important that the treatments we give are supported by good evidence, usually gathered from clinical trials. Unfortunately, we do not have good evidence for many of the CF treatments. We recently ran an exercise known as a James Lind Alliance Priority Setting Partnership (JLA PSP) to find out which the CF community feel are the top priority research questions. People with CF and those who look after them suggested questions to be answered by clinical trials. Through a series of online surveys and workshops these were then shortlisted to give a final top ten.Due to infection risk people with CF are advised not to mix, this meant we had to do things differently to the usual way JLA PSPs are carried out. We used videoconferencing to enable multiple people with CF to participate. Surveys were accessible online and promoted through social media. ABSTRACT:

Indexed as

Cross infectionCystic fibrosisJames Lind AlliancePatient involvementPriority setting partnershipSocial mediaVideoconferencing

Identifiers

PMID31452934
PMCPMC6701046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.